Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 2020

View Archived Issues

How the eye cleans itself up

Selective TGF-beta inhibition helps checkpoint blockade

Cabpirin tablets approved in Japan

Positive topline data from phase I clinical study of BX-001

Hydroxychloroquine and azithromycin show efficacy in patients with COVID-19

HDE biomarkers to predict idiosyncratic drug-induced liver injury

Kissei Pharmaceutical discloses new Egl nine homolog 1 inhibitors

New RET inhibitors discovered at Array BioPharma

Common form of muscular dystrophy causes damage through hypoxia

China's NMPA clears IND for trials of NTRK/ROS1 inhibitor HG-030

CTL1 is a potential therapeutic target in glioma

Bristol-Myers Squibb discovers RIP-1 inhibitors

Cocrystal Pharma synthesizes influenza virus replication inhibitors

ViiV Healthcare presents new HIV replication inhibitors

Convalescent plasma shows benefit in patients with COVID-19 and ARDS

Akero reports data from phase IIa study of AKR-001 in NASH

Dicerna reports initial data from PHYOX 3 long-term extension study of nedosiran for PH

Kiniksa reports early evidence of treatment response with mavrilimumab in severe COVID-19 pneumonia

Influenza antiviral drug favipiravir begins phase III trial in Japan for COVID-19

InflaRx begins clinical trial of IFX-1 in patients with severe COVID-19 pneumonia

ProQR reports interim data from phase I/II study of QR-421a for Usher syndrome

Klus begins first-in-human study of TROP2-targeting ADC SKB-264 in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...